Diagnos Inc DGNOF 价格预测与展望

Q: 技术分析指标如何适用于 DGNOF？

根据技术分析，Diagnos Inc 的综合信号为 Buy。Diagnos Inc 有 4 个买入信号，1 个中性信号和 2 个卖出信号。

Q: DGNOF 的斐波那契回调水平是多少？

Diagnos Inc 的斐波那契回调水平是 在 50% 和 61.8% 之间。

Q: Diagnos Inc 的 RSI 是多少？

Diagnos Inc 的 RSI 目前为 30.21，表明处于 中立 状态

Q: Diagnos Inc 接下来 12 个月的价格是多少？

Diagnos Inc DGNOF 接下来 12 个月的价格预计为 $1.03。

Q: Diagnos Inc 预计会涨到多高？

据华尔街分析师称，Diagnos Inc 预计将达到 $1.06 的高预测值。

主页

股票

DGNOF

预测

DGNOF 股票价格预测

Diagnos Inc

$0.22

-5.94%

$-0.01

截至今日：Jan 20, 12:59:41 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$0.2373

开盘价

$0.233

当日区间

$0.2232 - $0.233

52周范围

$0.13 - $0.29

交易量

16.2K

平均成交量

134.4K

每股收益（TTM）

-0.04

股息收益率

市值

$22.7M

什么是 DGNOF？

Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for DGNOF in the upcoming periods. Looking toward the future, our 2025 projection indicates an average price target of $1.03. The lowest target is $1.02 and the highest is $1.06. Empower your investment choices with our cutting-edge, data-driven analysis!

DGNOF 股价预测摘要

DGNOF的顶级分析师评级

基于 9 位分析师对 DGNOF 的股票评级，更新于 Jan 01, 2025

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for DGNOF. Our analysts highlight strong fundamentals and favorable market sentiment, positioning DGNOF for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: DGNOF is a Strong Buy candidate.

DGNOF stock price ended at $0.23 on 星期五, after rising 0.00%

On the latest trading day Jan 16, 2026, the stock price of DGNOF rose by 0.00%, climbing from $0.23 to $0.23. During the session, the stock saw a volatility of 4.35%, with prices oscillating between a daily low of $0.23 and a high of $0.24. Notably, trading volume dropped by 68.6K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 93.1K shares were traded, equating to a market value of approximately $23.4M.

DGNOF 技术面信号

技术面信号摘要

购买信号 4

中性信号 1

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

DGNOF目前显示4个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为--。总体而言，技术指标显示中期前景为Buy。

DGNOF 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 DGNOF 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 DGNOF？



DGNOF 的斐波那契回调水平是多少？



Diagnos Inc 的 RSI 是多少？



Diagnos Inc 接下来 12 个月的价格是多少？



Diagnos Inc 预计会涨到多高？



Diagnos Inc（DGNOF）价格

DGNOF 股价走势图